(LAX) A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - A strategy trial

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511008-17-00

Enrollment

110

Registered

2024-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced neuropathic pain

Brief summary

Pain intensity score during the last 4 weeks of treatment

Detailed description

Patient satisfaction of treatment, Side effect profile

Interventions

DRUGCymbalta 30 mg hard gastro-resistant capsules

DRUGVimpat 50 mg film-coated tablets

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain intensity score during the last 4 weeks of treatment	—

Secondary

Measure	Time frame
Patient satisfaction of treatment, Side effect profile	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026